Genetic test for cancer is less accurate for Black and Asian people
By Grace Wade,
New Scientist
| 09. 29. 2022
Genetic tests that predict the efficacy of certain cancer treatments aren’t as effective for people of African or Asian ancestry.
These tests measure the number of genetic mutations in solid tumours, or what’s known as tumour mutational burden (TMB). If someone has a tumour with 10 or more genetic mutations, they have a high TMB. Drugs called immune checkpoint inhibitors, which work by turning the immune system against tumours, have been shown to be quite effective against cancers in people with high TMB, but less so in people with fewer mutations.
The most accurate way to measure TMB is by doing genetic analyses of both tumour and normal tissue samples. This is called tumour-normal sequencing, and it ensures that mutations people inherent from their parents aren’t counted as tumour mutations. “If you don’t have matched normal tissue from an individual, you can actually overestimate the tumour mutational burden,” says Amin Nassar at Yale University in Connecticut.
Most treatment centres currently use tumour-only genetic sequencing, which estimates TMB by comparing results with genetic databases instead of a person’s own tissue...
Related Articles
By Elizabeth Dwoskin and Zoeann Murphy, The Washington Post | 10.01.2025
MEXICO CITY — When she walked into an IVF clinic in June, Alin Quintana knew it would be the last time she would try to conceive a child. She had prepared herself spiritually and mentally for the visit: She had traveled to a nearby...
By Rob Stein, NPR | 09.30.2025
Scientists have created human eggs containing genes from adult skin cells, a step that someday could help women who are infertile or gay couples have babies with their own genes but would also raise difficult ethical, social and legal issues...
By Jessica Mouzo, El País | 10.03.2025
DNA is the molecule of life: this double-helix structure, present in every cell in the body and organized into fragments called genes, stores the instructions for making organisms function. It is a highly precise biological machine, but sometimes it breaks...
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...